Author

Tomin E. Perea-Chamblee

Memorial Sloan Kettering Cancer CenterORCID 0000-0001-8366-7940Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Approach:machine learning (classical)· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Jian Carrot‐ZhangiD· 2 shared Alexander GuseviD· 1 shared Alicia J. LathamiD· 1 shared Aliya KhurramiD· 1 shared Andrew R. MardersteiniD· 1 shared Chaitanya BandlamudiiD· 1 shared Chris FongiD· 1 shared David B. SolitiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Jian Carrot‐ZhangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers

Johnathan Amsalem, Irina Ostrovnaya, Andrew R. Marderstein, Ying L. Liu, Tomin E. Perea-Chamblee, Vignesh Ravichandran, Justin Jee, Michael T. Conry, Aliya Khurram, Yelena M. Kemel, E. Kim, Semanti Mukherjee, Alicia J. Latham, Lauren Gabriele Banaszak, Ritika Kundra, , Joseph Vijai

The paper develops and validates a clinicogenomic risk model to predict second primary cancers in cancer survivors using genetic, clinical, and lifestyle factors.

medRxiv · Jun 22, 2026 · PreprintGenetic & Genomic Medicine

Meta-Analysis of Rare Cancers Leveraging Clinically Ascertained Cohorts Reveals Novel Germline Susceptibility Loci

Shaye Carver, Tomin E. Perea-Chamblee, Kodi Taraszka, Intae Moon, Xinran Yu, Yi Ding, Jian Carrot‐Zhang, Alexander Gusev

This study performs GWAS on 20 rare cancers using three cohorts, identifying nine novel susceptibility loci with replication across eight cancer types.

medRxiv · Apr 22, 2026 · PreprintGenetic & Genomic Medicine